# A Stretchable, Transparent, Photothermally Stimulated Laser-Induced Graphene Patch for Noninvasive Skin Tumor Treatment

**Authors:** Xiaoyu Xu, Le Cheng, Baoping Li, Xinyu Wang, Siyu Chen, Zihao Li, Li Zhou, Tengyue Liu, Yidan Zhou, Zhiqiang Li, Xin Li, Shi Chen, Meijia Gu, Ruquan Ye

PMC · DOI: 10.1021/acsnano.5c21102 · ACS Nano · 2026-03-05

## TL;DR

A new stretchable and transparent graphene patch effectively treats skin tumors in mice by triggering multiple cell death pathways with light.

## Contribution

A soft, stretchable laser-induced graphene patch with CuO for noninvasive melanoma treatment is developed.

## Key findings

- The patch effectively suppresses tumors in mice with two 1-hour phototherapy sessions.
- It induces apoptosis, cuproptosis, and ferroptosis in melanoma tissue.
- The patch inhibits tumor invasion and boosts antitumor immunity.

## Abstract

Melanoma causes over 80% of skin cancer-related deaths,
with conventional
therapies hampered by its aggressiveness, metastasis, and drug resistance.
Noninvasive, biocompatible strategies are promising for next-generation
cancer treatments. Herein, we developed a soft, stretchable laser-induced
graphene (LIG)-Cu/PDMS patch, consisting of CuO-embedded LIG (active
component) and biocompatible PDMS (flexible matrix). Chemically inert
and breathable, the patch minimizes toxic side effects. Upon photothermal
activation, it releases Cu2+ that accumulates in melanoma
tissue. In a mouse model, two 1-h phototherapy sessions achieved effective
tumor suppression within 10 days. Mechanistically, the patch enhances
reactive oxygen species production, inducing apoptosis, cuproptosis,
and ferroptosis. It also inhibits tumor invasion/metastasis and boosts
antitumor immunity, with stable performance enabling multiple uses
(energy-efficient and environmentally sustainable). This work demonstrates
graphene-based materials’ potential in cancer therapy via synergistic
activation of multiple cell death pathways and efficacy in low-temperature
phototherapy, expanding graphene’s application in malignant
tumor treatment and highlighting its clinical translation prospects.

## Linked entities

- **Chemicals:** Cu2+ (PubChem CID 27099)
- **Diseases:** melanoma (MONDO:0005105), skin cancer (MONDO:0002898)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Diseases:** metastasis (MESH:D009362), Skin Tumor (MESH:D012878), Melanoma (MESH:D008545), cancer (MESH:D009369)
- **Chemicals:** reactive oxygen species (MESH:D017382), CuO (MESH:C030973), Graphene (MESH:D006108), Cu2+ (-), Cu (MESH:D003300)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13001105/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13001105/full.md

## References

90 references — full list in the complete paper: https://tomesphere.com/paper/PMC13001105/full.md

---
Source: https://tomesphere.com/paper/PMC13001105